BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 018807
(350 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/120 (25%), Positives = 56/120 (46%), Gaps = 18/120 (15%)
Query: 94 EQILKRRRYF---VIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+KR+R+ ++ + SG+ YMH H+ +H+ L P +++L + EKD +
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES-KEKDCD-----I 163
Query: 151 RDLSFSVDISFQNLEEDPGTFSEGLWRRAAAAGAFTPMEKR-AFGIADDVYEAGLLLAYL 209
+ + F + FQ + + R A P R + DV+ AG++L L
Sbjct: 164 KIIDFGLSTCFQQ--------NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYIL 215
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/120 (25%), Positives = 56/120 (46%), Gaps = 18/120 (15%)
Query: 94 EQILKRRRYF---VIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+KR+R+ ++ + SG+ YMH H+ +H+ L P +++L + EKD +
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES-KEKDCD-----I 163
Query: 151 RDLSFSVDISFQNLEEDPGTFSEGLWRRAAAAGAFTPMEKR-AFGIADDVYEAGLLLAYL 209
+ + F + FQ + + R A P R + DV+ AG++L L
Sbjct: 164 KIIDFGLSTCFQQ--------NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYIL 215
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/120 (25%), Positives = 56/120 (46%), Gaps = 18/120 (15%)
Query: 94 EQILKRRRYF---VIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+KR+R+ ++ + SG+ YMH H+ +H+ L P +++L + EKD +
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES-KEKDCD-----I 163
Query: 151 RDLSFSVDISFQNLEEDPGTFSEGLWRRAAAAGAFTPMEKR-AFGIADDVYEAGLLLAYL 209
+ + F + FQ + + R A P R + DV+ AG++L L
Sbjct: 164 KIIDFGLSTCFQQ--------NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYIL 215
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 18/72 (25%), Positives = 40/72 (55%), Gaps = 9/72 (12%)
Query: 94 EQILKRRRYFVI---KLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+ R+R+ + ++ + +SG+ YMH + +H+ L P +++L + KDA +
Sbjct: 138 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES-KSKDA-----NI 191
Query: 151 RDLSFSVDISFQ 162
R + F + F+
Sbjct: 192 RIIDFGLSTHFE 203
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 18/72 (25%), Positives = 40/72 (55%), Gaps = 9/72 (12%)
Query: 94 EQILKRRRYFVI---KLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+ R+R+ + ++ + +SG+ YMH + +H+ L P +++L + KDA +
Sbjct: 139 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES-KSKDA-----NI 192
Query: 151 RDLSFSVDISFQ 162
R + F + F+
Sbjct: 193 RIIDFGLSTHFE 204
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 12/45 (26%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 94 EQILKRRRYF---VIKLFQGAMSGLAYMHDHDRLHQSLGPSSVIL 135
EQI+ R ++ + + +SG+ Y+H H+ +H+ + P +++L
Sbjct: 135 EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL 179
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 18/72 (25%), Positives = 40/72 (55%), Gaps = 9/72 (12%)
Query: 94 EQILKRRRYFVI---KLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+ R+R+ + ++ + +SG+ YMH + +H+ L P +++L + KDA +
Sbjct: 121 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES-KSKDA-----NI 174
Query: 151 RDLSFSVDISFQ 162
R + F + F+
Sbjct: 175 RIIDFGLSTHFE 186
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 18/72 (25%), Positives = 40/72 (55%), Gaps = 9/72 (12%)
Query: 94 EQILKRRRYFVI---KLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+ R+R+ + ++ + +SG+ YMH + +H+ L P +++L + KDA +
Sbjct: 115 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES-KSKDA-----NI 168
Query: 151 RDLSFSVDISFQ 162
R + F + F+
Sbjct: 169 RIIDFGLSTHFE 180
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 33.1 bits (74), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 18/73 (24%), Positives = 41/73 (56%), Gaps = 9/73 (12%)
Query: 94 EQILKRRRYFVIK---LFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+ R ++ + + + +SG+ Y+H H+ +H+ L P +++L + EKDA +
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES-KEKDAL-----I 178
Query: 151 RDLSFSVDISFQN 163
+ + F + F+N
Sbjct: 179 KIVDFGLSAVFEN 191
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 21/31 (67%)
Query: 106 KLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
+LFQ +SG+ Y H H +H+ L P +V+L+
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLD 150
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 32.7 bits (73), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 4/44 (9%)
Query: 97 LKRRRYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
L+ RYF+ +L +G L YMH +H+ L PS++++N E
Sbjct: 158 LEHVRYFLYQLLRG----LKYMHSAQVIHRDLKPSNLLVNENCE 197
>pdb|2VUN|A Chain A, The Crystal Structure Of Enamidase At 1.9 A Resolution - A
New Member Of The Amidohydrolase Superfamily
pdb|2VUN|B Chain B, The Crystal Structure Of Enamidase At 1.9 A Resolution - A
New Member Of The Amidohydrolase Superfamily
pdb|2VUN|C Chain C, The Crystal Structure Of Enamidase At 1.9 A Resolution - A
New Member Of The Amidohydrolase Superfamily
pdb|2VUN|D Chain D, The Crystal Structure Of Enamidase At 1.9 A Resolution - A
New Member Of The Amidohydrolase Superfamily
Length = 386
Score = 32.7 bits (73), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 11/98 (11%)
Query: 237 LQATREYCLADDRLLEAVKFLDLGEGAGWELLQVEIVFKVYRLSITPQILAIYVHIWKSH 296
LQA + + +D L+ A+ +L + AG + ++TP +L +VH+ S
Sbjct: 22 LQA--DTIVVEDGLIAAIGGEELMKDAGDAT-----IIDAAGSTVTPGLLDTHVHV--SG 72
Query: 297 MGFSPLQSPAFQEFIDKFLYGYVISLAAMLNPDFQQRP 334
++P Q +FI L+G V ++ + +P F RP
Sbjct: 73 GDYAPRQK--TMDFISSALHGGVTTMISAGSPHFPGRP 108
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 32.3 bits (72), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 4/44 (9%)
Query: 97 LKRRRYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
L+ RYF+ +L +G L YMH +H+ L PS++++N E
Sbjct: 157 LEHVRYFLYQLLRG----LKYMHSAQVIHRDLKPSNLLVNENCE 196
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 32.3 bits (72), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 32.3 bits (72), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 110 LFQ-LLQGLAFCHSHRVLHRDLKPENLLINT 139
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 32.0 bits (71), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 112 LFQ-LLQGLAFCHSHRVLHRDLKPENLLINT 141
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 32.0 bits (71), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 108 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 137
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 32.0 bits (71), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 32.0 bits (71), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 32.0 bits (71), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 32.0 bits (71), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 32.0 bits (71), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 108 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 137
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 32.0 bits (71), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPENLLINT 138
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 32.0 bits (71), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 108 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 137
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 32.0 bits (71), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 110 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 139
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 112 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 141
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 108 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 137
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 21/125 (16%)
Query: 94 EQILKRRR------YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLV 147
EQ +++RR ++LF+ G+ Y+H +H+ L PS++ L
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL---------VDT 172
Query: 148 PRLRDLSFSVDISFQNLEEDPGTFSEGLWRRAAAAGAFTPMEKRAFGIADDVYEAGLLLA 207
+++ F + S +N + T S+G R + + + +G D+Y GL+LA
Sbjct: 173 KQVKIGDFGLVTSLKN--DGKRTRSKGTLRYMSPE----QISSQDYGKEVDLYALGLILA 226
Query: 208 YLAFV 212
L V
Sbjct: 227 ELLHV 231
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 112 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 141
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 111 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 140
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 116 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 145
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 111 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 140
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 110 LFQ-LLQGLAFCHSHRVLHRDLKPENLLINT 139
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 138
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 108 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 137
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 32.0 bits (71), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 110 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 139
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 111 LFQ-LLQGLAFCHSHRVLHRDLKPENLLINT 140
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 111 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 140
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 116 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 145
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 32.0 bits (71), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 113 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 142
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 32.0 bits (71), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 112 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 141
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 32.0 bits (71), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 112 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 141
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 113 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 142
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 108 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 137
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 110 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 139
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GLA+ H H LH+ L P ++++NT
Sbjct: 112 LFQ-LLQGLAFCHSHRVLHRDLKPQNLLINT 141
>pdb|1YD9|A Chain A, 1.6a Crystal Structure Of The Non-Histone Domain Of The
Histone Variant Macroh2a1.1.
pdb|1YD9|B Chain B, 1.6a Crystal Structure Of The Non-Histone Domain Of The
Histone Variant Macroh2a1.1.
pdb|1YD9|C Chain C, 1.6a Crystal Structure Of The Non-Histone Domain Of The
Histone Variant Macroh2a1.1.
pdb|1YD9|D Chain D, 1.6a Crystal Structure Of The Non-Histone Domain Of The
Histone Variant Macroh2a1.1
Length = 193
Score = 32.0 bits (71), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 19/52 (36%), Positives = 26/52 (50%), Gaps = 6/52 (11%)
Query: 211 FVTFCEANVMDSLSLQRLLESTFRLDLQATREYCLADDRLLEAVKFLDLGEG 262
FV C + V S + LLE T + L LADDR L+++ F +G G
Sbjct: 93 FVIHCNSPVWGSDKCEELLEKTVKNCL------ALADDRKLKSIAFPSIGSG 138
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 31.6 bits (70), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 130 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 164
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 133 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 167
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 130 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 164
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 134 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 168
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 125 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 159
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 132 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 166
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 136 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 170
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 128 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 162
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 31.6 bits (70), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 126 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 160
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 31.6 bits (70), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 31.6 bits (70), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTCD 162
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 31.6 bits (70), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 132 LRGLKYIHSANVLHRDLKPSNLLLNTTCD 160
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 31.6 bits (70), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCD 166
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 31.6 bits (70), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 139 LRGLKYIHSANVLHRDLKPSNLLLNTTCD 167
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 31.6 bits (70), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 148 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTCD 182
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 31.6 bits (70), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 36/136 (26%), Positives = 61/136 (44%), Gaps = 23/136 (16%)
Query: 101 RYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT--IVEKDAAYLVPRLRDLSFSVD 158
R F+ +L +G L Y+H + LH+ L P+++ +NT +V K + + R+ D +S
Sbjct: 123 RLFMYQLLRG----LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS-- 176
Query: 159 ISFQNLEEDPGTFSEGL---WRRAAAAGAFTPMEKRAFGIADDVYEAGLLLAYLAFVTFC 215
G SEGL W R+ +P + A D++ AG + A +
Sbjct: 177 --------HKGHLSEGLVTKWYRSPRL-LLSP---NNYTKAIDMWAAGCIFAEMLTGKTL 224
Query: 216 EANVMDSLSLQRLLES 231
A + +Q +LES
Sbjct: 225 FAGAHELEQMQLILES 240
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 31.2 bits (69), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 10/28 (35%), Positives = 20/28 (71%)
Query: 109 QGAMSGLAYMHDHDRLHQSLGPSSVILN 136
GA+ GLAY+H H+ +H+ + +++L+
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLS 149
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 31.2 bits (69), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXD 162
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 31.2 bits (69), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTXD 166
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 31.2 bits (69), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTXD 166
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 31.2 bits (69), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXD 162
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 31.2 bits (69), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
+ GL Y+H + LH+ L PS+++LNT +
Sbjct: 134 LRGLKYIHSANVLHRDLKPSNLLLNTTXD 162
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 31.2 bits (69), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 24/36 (66%), Gaps = 4/36 (11%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
YF+ ++ +G L Y+H + LH+ L PS+++LNT
Sbjct: 130 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNT 161
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 31.2 bits (69), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 13/39 (33%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS++++NT +
Sbjct: 148 YFLYQILRG----LKYIHSANVLHRDLKPSNLLINTTCD 182
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 31.2 bits (69), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 25/39 (64%), Gaps = 4/39 (10%)
Query: 102 YFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE 140
YF+ ++ +G L Y+H + LH+ L PS+++LNT +
Sbjct: 148 YFLYQILRG----LKYIHSANVLHRDLKPSNLLLNTTXD 182
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 21/31 (67%), Gaps = 1/31 (3%)
Query: 107 LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
LFQ + GL++ H H LH+ L P ++++NT
Sbjct: 109 LFQ-LLQGLSFCHSHRVLHRDLKPQNLLINT 138
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 10/28 (35%), Positives = 20/28 (71%)
Query: 109 QGAMSGLAYMHDHDRLHQSLGPSSVILN 136
GA+ GLAY+H H+ +H+ + +++L+
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLS 188
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/72 (23%), Positives = 39/72 (54%), Gaps = 9/72 (12%)
Query: 94 EQILKRRRYFVI---KLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRL 150
++I+ R+R+ + ++ + +SG+ Y H + +H+ L P +++L + KDA +
Sbjct: 115 DEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLES-KSKDA-----NI 168
Query: 151 RDLSFSVDISFQ 162
R + F + F+
Sbjct: 169 RIIDFGLSTHFE 180
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 30.4 bits (67), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 25/111 (22%)
Query: 101 RYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVE-KDAAYLVPRLRDLSFSVDI 159
+YF +L QG LA+ H++ LH+ L P ++++N + K + + R +F + +
Sbjct: 111 KYFQWQLLQG----LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR----AFGIPV 162
Query: 160 SFQNLEEDPGTFSE---GLWRRAAAAGAFTPMEKRAFGIADDVYEAGLLLA 207
+ TFS LW RA M R + + D++ G +LA
Sbjct: 163 N---------TFSSEVVTLWYRAPDVL----MGSRTYSTSIDIWSCGCILA 200
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 11/47 (23%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 94 EQILKRRRYFVIK---LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
++I+ R+++ + + + +SG Y+H H+ +H+ L P +++L +
Sbjct: 93 DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLES 139
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 10/25 (40%), Positives = 18/25 (72%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILN 136
++G+AY HD LH+ L P ++++N
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLIN 134
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 10/25 (40%), Positives = 18/25 (72%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILN 136
++G+AY HD LH+ L P ++++N
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLIN 134
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 10/25 (40%), Positives = 18/25 (72%)
Query: 112 MSGLAYMHDHDRLHQSLGPSSVILN 136
++G+AY HD LH+ L P ++++N
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLIN 134
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 11/47 (23%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 94 EQILKRRRYFVIK---LFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
++I+ R+++ + + + +SG Y+H H+ +H+ L P +++L +
Sbjct: 110 DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLES 156
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 30.0 bits (66), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 12/31 (38%), Positives = 20/31 (64%)
Query: 106 KLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
+LFQ +S + Y H H +H+ L P +V+L+
Sbjct: 115 RLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 30.0 bits (66), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 12/31 (38%), Positives = 20/31 (64%)
Query: 106 KLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
+LFQ +S + Y H H +H+ L P +V+L+
Sbjct: 115 RLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
>pdb|1ZR3|A Chain A, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.1 (Form B)
pdb|1ZR3|B Chain B, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.1 (Form B)
pdb|1ZR3|C Chain C, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.1 (Form B)
pdb|1ZR3|D Chain D, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.1 (Form B)
pdb|2FXK|A Chain A, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.1 (Form A)
pdb|2FXK|B Chain B, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.1 (Form A)
pdb|3IID|A Chain A, Crystal Structure Of The Macro Domain Of Human Histone
Macroh2a1.1 In Complex With Adp-Ribose (Form A)
pdb|3IIF|A Chain A, Crystal Structure Of The Macro Domain Of Human Histone
Macroh2a1.1 In Complex With Adp-Ribose (Form B)
pdb|3IIF|B Chain B, Crystal Structure Of The Macro Domain Of Human Histone
Macroh2a1.1 In Complex With Adp-Ribose (Form B)
pdb|3IIF|C Chain C, Crystal Structure Of The Macro Domain Of Human Histone
Macroh2a1.1 In Complex With Adp-Ribose (Form B)
Length = 211
Score = 29.6 bits (65), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 17/52 (32%), Positives = 26/52 (50%), Gaps = 6/52 (11%)
Query: 211 FVTFCEANVMDSLSLQRLLESTFRLDLQATREYCLADDRLLEAVKFLDLGEG 262
FV C + V + + LLE T + L LADD+ L+++ F +G G
Sbjct: 111 FVIHCNSPVWGADKCEELLEKTVKNCL------ALADDKKLKSIAFPSIGSG 156
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 12/44 (27%), Positives = 26/44 (59%)
Query: 94 EQILKRRRYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
E + ++ Y I L + SG+A++H +H+ L P +++++T
Sbjct: 107 ENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
>pdb|1ZR5|A Chain A, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.2
pdb|1ZR5|B Chain B, Crystal Structure Of The Macro-Domain Of Human Core
Histone Variant Macroh2a1.2
Length = 214
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 17/52 (32%), Positives = 26/52 (50%), Gaps = 6/52 (11%)
Query: 211 FVTFCEANVMDSLSLQRLLESTFRLDLQATREYCLADDRLLEAVKFLDLGEG 262
FV C + V + + LLE T + L LADD+ L+++ F +G G
Sbjct: 114 FVIHCNSPVWGADKCEELLEKTVKNCL------ALADDKKLKSIAFPSIGSG 159
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 29.3 bits (64), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 12/44 (27%), Positives = 26/44 (59%)
Query: 94 EQILKRRRYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
E + ++ Y I L + SG+A++H +H+ L P +++++T
Sbjct: 107 ENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 28.9 bits (63), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 12/44 (27%), Positives = 26/44 (59%)
Query: 94 EQILKRRRYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
E + ++ Y I L + SG+A++H +H+ L P +++++T
Sbjct: 125 ENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 168
>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1
Length = 361
Score = 28.9 bits (63), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 1/74 (1%)
Query: 101 RYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRLRDLSFSVDIS 160
R V++L + L Y+H+H+ +H + S+++LN D YLV + +
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN-YKNPDQVYLVDYGLAYRYCPEGV 209
Query: 161 FQNLEEDPGTFSEG 174
+ +EDP +G
Sbjct: 210 HKEYKEDPKRCHDG 223
>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1
pdb|2KUL|A Chain A, Solution Structure Of Human Vaccinia Related Kinase
1(Vrk1)
Length = 368
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 1/74 (1%)
Query: 101 RYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNTIVEKDAAYLVPRLRDLSFSVDIS 160
R V++L + L Y+H+H+ +H + S+++LN D YLV + +
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN-YKNPDQVYLVDYGLAYRYCPEGV 209
Query: 161 FQNLEEDPGTFSEG 174
+ +EDP +G
Sbjct: 210 HKEYKEDPKRCHDG 223
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 12/44 (27%), Positives = 26/44 (59%)
Query: 94 EQILKRRRYFVIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
E + ++ Y I L + SG+A++H +H+ L P +++++T
Sbjct: 125 ENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 168
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 28.9 bits (63), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 11/32 (34%), Positives = 21/32 (65%)
Query: 105 IKLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
I L Q SGLA++H + +H+ L P +++++
Sbjct: 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS 152
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 28.9 bits (63), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 8/31 (25%), Positives = 23/31 (74%)
Query: 106 KLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
K+ QGA +G+ ++H++ +H+ + ++++L+
Sbjct: 128 KIAQGAANGINFLHENHHIHRDIKSANILLD 158
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 28.5 bits (62), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 8/31 (25%), Positives = 23/31 (74%)
Query: 106 KLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
K+ QGA +G+ ++H++ +H+ + ++++L+
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLD 167
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 28.5 bits (62), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 8/31 (25%), Positives = 23/31 (74%)
Query: 106 KLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
K+ QGA +G+ ++H++ +H+ + ++++L+
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLD 167
>pdb|2RI0|A Chain A, Crystal Structure Of Glucosamine 6-Phosphate Deaminase
(Nagb) From S. Mutans
pdb|2RI0|B Chain B, Crystal Structure Of Glucosamine 6-Phosphate Deaminase
(Nagb) From S. Mutans
Length = 234
Score = 28.5 bits (62), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 251 LEAVKFLDLGEGA--GWELLQVEIVF--KVYRLSITPQILAIYVHIWKSHMGFSPLQSPA 306
++ +K + EG+ + +L+ EI F K L+ L +Y I +SH+ FS + S
Sbjct: 2 MKTIKVKNKTEGSKVAFRMLEEEITFGAKTLGLATGSTPLELYKEIRESHLDFSDMVSIN 61
Query: 307 FQEFI-----DKFLYGY 318
E++ DK Y Y
Sbjct: 62 LDEYVGLSADDKQSYAY 78
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 28.5 bits (62), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 8/31 (25%), Positives = 23/31 (74%)
Query: 106 KLFQGAMSGLAYMHDHDRLHQSLGPSSVILN 136
K+ QGA +G+ ++H++ +H+ + ++++L+
Sbjct: 131 KIAQGAANGINFLHENHHIHRDIKSANILLD 161
>pdb|2RI1|A Chain A, Crystal Structure Of Glucosamine 6-Phosphate Deaminase
(Nagb) With Glcn6p From S. Mutans
pdb|2RI1|B Chain B, Crystal Structure Of Glucosamine 6-Phosphate Deaminase
(Nagb) With Glcn6p From S. Mutans
Length = 235
Score = 28.5 bits (62), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 251 LEAVKFLDLGEGA--GWELLQVEIVF--KVYRLSITPQILAIYVHIWKSHMGFSPLQSPA 306
++ +K + EG+ + +L+ EI F K L+ L +Y I +SH+ FS + S
Sbjct: 3 MKTIKVKNKTEGSKVAFRMLEEEITFGAKTLGLATGSTPLELYKEIRESHLDFSDMVSIN 62
Query: 307 FQEFI-----DKFLYGY 318
E++ DK Y Y
Sbjct: 63 LDEYVGLSADDKQSYAY 79
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 28.5 bits (62), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%), Gaps = 1/33 (3%)
Query: 105 IKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
I L+Q + G+A+ H H LH+ L P ++++N+
Sbjct: 123 IYLYQ-LLRGVAHCHQHRILHRDLKPQNLLINS 154
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 28.1 bits (61), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%), Gaps = 1/33 (3%)
Query: 105 IKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
I L+Q + G+A+ H H LH+ L P ++++N+
Sbjct: 123 IYLYQ-LLRGVAHCHQHRILHRDLKPQNLLINS 154
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 28.1 bits (61), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 9/34 (26%), Positives = 20/34 (58%)
Query: 104 VIKLFQGAMSGLAYMHDHDRLHQSLGPSSVILNT 137
+ + Q + GL Y+H ++H+ + +++LNT
Sbjct: 127 IATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 28.1 bits (61), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 10/26 (38%), Positives = 18/26 (69%)
Query: 111 AMSGLAYMHDHDRLHQSLGPSSVILN 136
+ GL Y+H H LH+ L P++++L+
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLD 146
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.136 0.402
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,019,824
Number of Sequences: 62578
Number of extensions: 394627
Number of successful extensions: 1178
Number of sequences better than 100.0: 116
Number of HSP's better than 100.0 without gapping: 95
Number of HSP's successfully gapped in prelim test: 21
Number of HSP's that attempted gapping in prelim test: 1078
Number of HSP's gapped (non-prelim): 121
length of query: 350
length of database: 14,973,337
effective HSP length: 100
effective length of query: 250
effective length of database: 8,715,537
effective search space: 2178884250
effective search space used: 2178884250
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 52 (24.6 bits)